Drug intelligence / Profile preview

Xiao-Feng-San + Qing-Shang-Fang-Feng-Tang

Development stage: Unknown
Lead developer: Chang Gung Memorial Hospital
Modality: Small Molecules
Administration: Oral

Overview

Xiao-Feng-San + Qing-Shang-Fang-Feng-Tang is an investigational botanical combination therapy developed by Chang Gung Memorial Hospital for the treatment of chronic urticaria. This therapeutic approach involves a fixed mixture of two traditional Chinese medicine (TCM) formulas: Xiao-Feng-San (XFS) and Qing-Shang-Fang-Feng-Tang (QSFFT). In clinical studies, it is evaluated as an adjuvant therapy to the antihistamine levocetirizine. The mechanism of action involves anti-allergic, anti-oxidative, and anti-inflammatory effects, as well as the modulation of the Th1/Th2 immune balance. The treatment is administered orally in capsule form and has reached Phase III clinical trials in Taiwan.

Other names: Xiao-Feng-SanQing-Shang-Fang-Feng-TangXFSQSFFTCHM-Chang Gung Memorial Hospital-chronic urticaria

Beyond the preview

Go deeper on Xiao-Feng-San + Qing-Shang-Fang-Feng-Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao-Feng-San + Qing-Shang-Fang-Feng-Tang.

Explore the full profile